Expertise in
1
conditions

Qiu Q. Li

Chengdu, CN 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
1
conditions
Chengdu, CN 

Overview

Qiu Li practices practicing medicine in Chengdu, China.

Li is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Liver Cancer, Febrile Neutropenia, Colorectal Cancer, Hepato-Pancreato-Biliary Surgery, and Liver Transplant.

They are actively involved in clinical research, co-authoring 138 peer reviewed articles and participating in 2 clinical trials.

Locations

Chengdu, China
Other Locations
China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase I, Open-label, Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Preliminary Efficacy of KC1036 in the Patients with Advanced Recurrent or Metastatic Solid Tumors
A Phase I, Open-label, Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Preliminary Efficacy of KC1036 in the Patients with Advanced Recurrent or Metastatic Solid Tumors
Enrollment Status: Recruiting
Publish Date: October 17, 2024
Intervention Type: Drug
Study Phase: Phase 1
An Open-Label, Phase 1, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activities of CMG901 in Subjects With Advanced Unresectable or Metastatic Solid Tumor
An Open-Label, Phase 1, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activities of CMG901 in Subjects With Advanced Unresectable or Metastatic Solid Tumor
Enrollment Status: Completed
Publish Date: February 12, 2025
Intervention Type: Drug
Study Drug: CMG901
Study Phase: Phase 1
View 1 Less Clinical Trial

138 Total Publications

Cost-effectiveness analysis of enfortumab vedotin and pembrolizumab versus chemotherapy for patients with untreated advanced urothelial cancer in the United Kingdom.
Cost-effectiveness analysis of enfortumab vedotin and pembrolizumab versus chemotherapy for patients with untreated advanced urothelial cancer in the United Kingdom.
Journal: BMJ open
Published: December 08, 2025

Frequently Asked Questions about Qiu Q. Li

Is Qiu Q. Li a top-rated expert for Liver Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Qiu Q. Li is classified as an Advanced expert for Liver Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Qiu Q. Li participate in research or clinical trials?

Yes. Qiu Q. Li has published 138 articles and abstracts on conditions like Liver Cancer. You can view a list of Qiu Q. Li's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Li's expertise for a condition
ConditionClose
      View All 19 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile